In this downloadable slideset, Scott Kopetz, MD, PhD, FACP, reviews best practice for testing and interpreting data on tumor mutational burden and microsatellite instability/mismatch repair deficiency in multiple tumor types.
In this downloadable slideset, David R. Spigel, MD, reviews key data and best practice for the use of PD-L1 biomarker testing in patients who may be eligible for immune checkpoint inhibitors.
In this downloadable slideset, Jason N. Rosenbaum, MD, reviews available technologies and current best practice for biomarker testing in patients who may be eligible to receive immune checkpoint inhibitors.
In this downloadable slideset, Scott Kopetz, MD, PhD, FACP, provides an overview of immune checkpoint inhibitors in cancer therapy.
In this downloadable slideset, David R. Spigel, MD, highlights emerging data and next steps for the use of biomarkers in cancer immunotherapy.
Expert faculty Scott Kopetz, MD, PhD, FACP; Jason N. Rosenbaum, MD; and David R. Spigel, MD, discuss recent advances in biomarkers for cancer immunotherapy including clinical utility and future directions.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.